Neoadjuvant chemotherapy by liposomal doxorubicin boosts immune protection of tumor membrane antigens-based nanovaccine.
Chen Y, Qin H, Li N, Wei Y, Lin Y, Deng R, Ding H, Lv Y, Ma T, Li R, Xiong C, Zheng G, Chen H, Shi J, Zhao Y, Zhao R, Nie G.
Chen Y, et al. Among authors: ma t.
Cell Rep Med. 2024 Dec 12:101877. doi: 10.1016/j.xcrm.2024.101877. Online ahead of print.
Cell Rep Med. 2024.
PMID: 39708812
Free article.